DHR · Danaher Corp
United States · RS rating 84 · As of 2026-11-03
| Price | 230.11 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 69 / 87 / 58 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 49 / 45 / 53 |
| Industry group (rank) | Medical-Diversified (4) |
| EPS growth Q/Q | +32.3% |
| Sales growth Q/Q | +13.0% |
| Distance from 52-week high | +4.9% |
| Market cap (USD) | $126.4B |